|
Clinical Trial Ceftriaxone in Subjects With ALS |
Multiple U.S. Locations |
Completed |
Amyotrophic Lateral Sclerosis, ALS |
|
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) |
Multiple U.S. Locations |
Completed |
Relapsing Remitting Multiple Sclerosis |
|
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) |
Multiple U.S. Locations |
Completed |
Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease, Primary Lateral Sclerosis, Nervous System Diseases, Hereditary Spastic Paraparesis |
|
Zenapax to Treat Multiple Sclerosis |
Maryland* |
Completed |
Multiple Sclerosis |
|
Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS) |
Maryland* |
Completed |
Primary Progressive Multiple Sclerosis |
|
Natural History of Optic Neuritis |
International Locations |
Completed |
Multiple Sclerosis |
|
Potential Risk Factors for Stroke |
Maryland |
Completed |
Carotid Atherosclerosis, Cerebrovascular Accident, Diabetes Mellitus, Hypercholesterolemia, Hypertension |
|
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging |
Maryland* |
Completed |
Multiple Sclerosis |
|
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis |
Maryland |
Completed |
Primary Lateral Sclerosis, Hereditary Spastic Paraplegia, Amyotrophic Lateral Sclerosis |
|
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis |
Maryland* |
Completed |
Multiple Sclerosis |
